Sight Sciences, Inc. (SGHT)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Interventional Glaucoma	75.72M	75.90M	74.31M	65.59M	46.50M
Interventional Dry Eye	1.64M	3.96M	6.75M	5.74M	2.46M
Total	77.36M	79.87M	81.06M	71.33M	48.96M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
United States	77.36M	79.87M	81.06M	71.33M	48.96M
Total	77.36M	79.87M	81.06M	71.33M	48.96M

Data Source: S&P Global Market Intelligence Last updated: May 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error